Here are six key trends:
1. The market to grow to around $4.2 billion by 2019.
2. It is estimated to grow at a compound annual growth rate of 5 percent from 2014 to 2019.
3. Factors such as growing incidences of ocular disorders increase in geriatric population as well as technological advancements are driving the growth of the market.
4. However, a general lack of awareness among people on eye disorders, poor primary healthcare infrastructure and a lack of healthcare insurance are restraining the market.
5. The European ophthalmology surgery devices market is considered the second largest market, preceded by North America.
6. Key players in the North America market are Abbott Laboratories, Alcon, Allergan and Bausch & Lomb.
More articles on ASC issues:
ASC company financial report: 5 key companies — April 30, 2015
Wisconsin outpatient surgery, medical building wins approval — 5 key notes
Two NY physicians get a step closer to new ASC approval — 8 things to know
